TAS1R1

Chr 1

taste 1 receptor member 1

Also known as: GM148, GPR70, T1R1, TR1

The protein is a G protein-coupled receptor that forms the TAS1R1+3 heterodimeric amino acid taste receptor, which responds to L-amino acids and umami taste stimuli like monosodium glutamate. This gene is not well-established as a cause of human disease, as loss-of-function variants are extremely well-tolerated in the population (pLI ~0). Any potential phenotypes would likely involve taste perception abnormalities rather than neurological disease.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
10
Pubs (1 yr)
52
P/LP submissions
0%
P/LP missense
1.17
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryTAS1R1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
52 unique Pathogenic / Likely Pathogenic· 97 VUS of 180 total submissions
Some data sources returned errors (1)

pubtator: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.17LOEUF
pLI 0.000
Z-score 0.84
OE 0.83 (0.591.17)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.41Z-score
OE missense 0.95 (0.881.02)
463 obs / 488.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.83 (0.591.17)
00.351.4
Missense OE0.95 (0.881.02)
00.61.4
Synonymous OE0.95
01.21.6
LoF obs/exp: 23 / 27.8Missense obs/exp: 463 / 488.2Syn Z: 0.53
DN
0.6939th %ile
GOF
0.76top 25%
LOF
0.2969th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

180 submitted variants in ClinVar

Classification Summary

Pathogenic51
Likely Pathogenic1
VUS97
Likely Benign11
Benign5
51
Pathogenic
1
Likely Pathogenic
97
VUS
11
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
51
0
51
Likely Pathogenic
0
0
1
0
1
VUS
0
91
6
0
97
Likely Benign
1
10
0
0
11
Benign
0
3
1
1
5
Total1104591165

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TAS1R1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →